Your session is about to expire
← Back to Search
Nasal Congestion Relief Device
Sonu Treatment Group for Nasal Congestion and Inflammation (SCORE Trial)
N/A
Waitlist Available
Led By Jacob Johnson, MD
Research Sponsored by Third Wave Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights
Summary
This trial tests Sonu, a headband that uses sound vibrations from a smartphone app, to help people with severe nasal congestion due to rhinitis. The vibrations aim to clear the nasal passages and make breathing easier. The device has been studied for its effectiveness in reducing nasal congestion.
Eligible Conditions
- Nasal Congestion and Inflammation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Primary Effectiveness
Secondary study objectives
Secondary Effectiveness
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Sonu Treatment GroupExperimental Treatment1 Intervention
Patients will receive acoustic resonance therapy for 15 minutes, twice a day, for two weeks using Sonu.
Group II: Sham Control GroupPlacebo Group1 Intervention
Patients will receive non-resonant acoustic energy for 15 minutes, twice a day, for two weeks using Sonu.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sonu
2022
N/A
~60
Find a Location
Who is running the clinical trial?
Third Wave TherapeuticsLead Sponsor
3 Previous Clinical Trials
325 Total Patients Enrolled
Jacob Johnson, MDPrincipal InvestigatorSan Francisco Otolaryngology Medical Group
4 Previous Clinical Trials
341 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You experience at least two hours of nasal congestion within a 24 hour period.You have a history of growths or masses in your nose.You must be at least 18 years of age to participate in this study.You have experienced a prolonged bout of nasal congestion prior to commencing treatment.You had a sinus infection or used certain nose medications in the last month.
Research Study Groups:
This trial has the following groups:- Group 1: Sham Control Group
- Group 2: Sonu Treatment Group
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger